Press
back to blog

Entos (Now Iambic) Transforms Drug Discovery and Design With NVIDIA AI-Powered Molecular Simulation

Press
This is some text inside of a div block.
November 9, 2021

Media Contacts

Related announcements

View All
View All
November 1, 2024

Previewing NeuralPLexer3: Towards fully AI-enabled Structure-Based Drug Discovery

Read more
November 1, 2024

Previewing NeuralPLexer3: Towards fully AI-enabled Structure-Based Drug Discovery

Read more
October 29, 2024

Iambic Therapeutics Announces “Enchant,” an AI Platform that Predicts Clinical Outcomes from the Earliest Stages of Drug Discovery

Read more
October 29, 2024

Iambic Therapeutics Announces “Enchant,” an AI Platform that Predicts Clinical Outcomes from the Earliest Stages of Drug Discovery

Read more
October 29, 2024

Enchant whitepaper: Breaking the data wall between lab and clinic

Read more
October 29, 2024

Enchant whitepaper: Breaking the data wall between lab and clinic

Read more